Clinical Trials

Showing trials with last updates posted in 2026.

NCT03150329 | ACTIVE_NOT_RECRUITING | PHASE1
52 participants

Pembrolizumab and Vorinostat in Patients With Relapsed or Refractory DLBCL, FCL or HL.

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-21
Start Date:
2017-07-18
Completion:
2023-06-23
Conditions
  • Grade 3b Follicular Lymphoma
  • Recurrent B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between DLBCL and Classic HL
  • Recurrent Classic Hodgkin Lymphoma
  • Recurrent Diffuse Large B-Cell Lymphoma
  • Recurrent Follicular Lymphoma
  • Recurrent Grade 1 Follicular Lymphoma
  • Recurrent Grade 2 Follicular Lymphoma
  • Recurrent Grade 3a Follicular Lymphoma
  • Recurrent Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma
  • Recurrent Transformed Non-Hodgkin Lymphoma
  • Refractory B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between DLBCL and Classic HL
  • Refractory Classic Hodgkin Lymphoma
  • Refractory Diffuse Large B-Cell Lymphoma
  • Refractory Follicular Lymphoma
  • Refractory Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma
  • Refractory Transformed Non-Hodgkin Lymphoma
Interventions
  • OTHER
  • BIOLOGICAL
  • DRUG
NCT03113500 | ACTIVE_NOT_RECRUITING | PHASE2
48 participants

Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With CD30-Positive Peripheral T-cell Lymphoma

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-21
Start Date:
2017-05-25
Completion:
2021-07-16
Conditions
  • Adult T-Cell Leukemia/Lymphoma
  • Anaplastic Large Cell Lymphoma, ALK-Negative
  • Anaplastic Large Cell Lymphoma, ALK-Positive
  • Angioimmunoblastic T-Cell Lymphoma
  • Ann Arbor Stage II Noncutaneous Anaplastic Large Cell Lymphoma
  • Ann Arbor Stage III Noncutaneous Anaplastic Large Cell Lymphoma
  • Ann Arbor Stage IV Noncutaneous Anaplastic Large Cell Lymphoma
  • Enteropathy-Associated T-Cell Lymphoma
  • Hepatosplenic T-Cell Lymphoma
  • Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma
  • Peripheral T-Cell Lymphoma, Not Otherwise Specified
Interventions
  • DRUG
  • OTHER
NCT03012789 | COMPLETED | NA
30 participants

Surgical Intervention and the NETest

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-21
Start Date:
2017-05-15
Completion:
2025-12-01
Conditions
  • Neuroendocrine Tumor
  • Gastroenteropancreatic
Interventions
  • PROCEDURE
No Results Yet
NCT02703220 | RECRUITING | PHASE4
100 participants

Sleep Apnea in Elderly

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-21
Start Date:
2015-07-03
Completion:
2027-07-30
Conditions
  • Sleep Apnea
  • Elderly Adults
Interventions
  • OTHER
  • DRUG
No Results Yet
NCT02582021 | RECRUITING
220 participants

WISE CVD - Continuation (WISE HFpEF)

Study Type:
OBSERVATIONAL
Last Updated:
2026-08-21
Start Date:
2015-10-31
Completion:
2030-02-28
Conditions
  • Microvascular Coronary Dysfunction
  • Cardiovascular Disease
Interventions
  • PROCEDURE
No Results Yet
NCT02466971 | ACTIVE_NOT_RECRUITING | PHASE3
450 participants

Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-21
Start Date:
2016-05-10
Completion:
2023-01-26
Conditions
  • Advanced Vaginal Adenocarcinoma
  • Advanced Vaginal Adenosquamous Carcinoma
  • Advanced Vaginal Squamous Cell Carcinoma
  • Cervical Adenocarcinoma
  • Cervical Adenosquamous Carcinoma
  • Cervical Squamous Cell Carcinoma
  • Stage IB2 Cervical Cancer AJCC v6 and v7
  • Stage II Cervical Cancer AJCC v7
  • Stage II Vaginal Cancer AJCC v6 and v7
  • Stage IIA Cervical Cancer AJCC v7
  • Stage IIB Cervical Cancer AJCC v6 and v7
  • Stage III Vaginal Cancer AJCC v6 and v7
  • Stage IIIB Cervical Cancer AJCC v6 and v7
  • Stage IV Vaginal Cancer AJCC v6 and v7
  • Stage IVA Cervical Cancer AJCC v6 and v7
  • Stage IVA Vaginal Cancer AJCC v6 and v7
  • Unresectable Vaginal Carcinoma
  • Vaginal Adenocarcinoma
  • Vaginal Adenosquamous Carcinoma
  • Vaginal Carcinoma
  • Vaginal Squamous Cell Carcinoma, Not Otherwise Specified
Interventions
  • RADIATION
  • DRUG
  • OTHER
NCT02160015 | ACTIVE_NOT_RECRUITING | PHASE1
12 participants

Lenalidomide, Ibrutinib, and Rituximab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma That Is Metastatic or Cannot Be Removed by Surgery

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-21
Start Date:
2014-05-20
Completion:
2017-03-27
Conditions
  • Recurrent Chronic Lymphocytic Leukemia
  • Recurrent Small Lymphocytic Lymphoma
  • Refractory Chronic Lymphocytic Leukemia
  • Refractory Small Lymphocytic Lymphoma
Interventions
  • PROCEDURE
  • DRUG
  • BIOLOGICAL
No Results Yet
NCT01946529 | COMPLETED | PHASE2
24 participants

Therapeutic Trial for Patients With Ewing Sarcoma Family of Tumor and Desmoplastic Small Round Cell Tumors

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-21
Start Date:
2013-12-27
Completion:
2015-08-31
Conditions
  • Desmoplastic Small Round Cell Tumor
  • Ewing Sarcoma of Bone or Soft Tissue
  • Localized Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor
  • Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor
Interventions
  • DRUG
  • PROCEDURE
  • RADIATION
NCT01893307 | ACTIVE_NOT_RECRUITING | PHASE3
440 participants

Intensity-Modulated Proton Beam Therapy or Intensity-Modulated Photon Therapy in Treating Patients With Stage III-IVB Oropharyngeal Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-21
Start Date:
2013-08-26
Completion:
2031-12-31
Conditions
  • Stage III Oropharyngeal Squamous Cell Carcinoma AJCC v7
  • Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7
  • Stage IVB Oropharyngeal Squamous Cell Carcinoma AJCC v7
Interventions
  • RADIATION
  • OTHER
No Results Yet
NCT07777900 | ENROLLING_BY_INVITATION
100 participants

Glycated Albumin Monitoring

Study Type:
OBSERVATIONAL
Last Updated:
2026-08-20
Start Date:
2025-07-07
Completion:
2027-01-15
Conditions
  • Diabetes
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page